The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 19, 2024

Filed:

Jul. 28, 2022
Applicants:

Janssen Pharmaceuticals, Inc., Titusville, NJ (US);

Glaxosmithkline Biologicals S.a., Rixensart, BE;

Inventors:

Jeroen Geurtsen, Vleuten, NL;

Jan Theunis Poolman, Vogelenzang, NL;

Kellen Cristhina Fae, Mainz, DE;

Pieter Jan Burghout, Pijnacker, NL;

Eveline Marleen Weerdenburg, Uithoorn, NL;

Patricia Ibarra Yon, Solothum, CH;

Darren Robert Abbanat, Cornwal, NY (US);

Stefan Jochen Kemmler, Zurich, CH;

Michael Thomas Kowarik, Zurich, CH;

Manuela Mally, Watt, CH;

Veronica Gambillara Fonck, Meilen, CH;

Martin Edward Braun, Cham, CH;

Maria Paula Carranza Sandmeier, Rudolfstetten, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/108 (2006.01); A61K 39/00 (2006.01); A61P 31/04 (2006.01); A61P 37/04 (2006.01); C07K 14/21 (2006.01); C07K 19/00 (2006.01); C12N 9/10 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0258 (2013.01); A61P 31/04 (2018.01); A61P 37/04 (2018.01); C07K 14/21 (2013.01); C07K 19/00 (2013.01); C12N 9/1051 (2013.01); C12Y 204/01 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6037 (2013.01);
Abstract

A bioconjugate of anglucosylated O4 antigen polysaccharide covalently linked to a carrier protein and compositions thereof are provided. Also provided are recombinant host cells for producing the bioconjugate, and methods of producing the bioconjugate using the recombinant host cells. The recombinant host cells contain a nucleic acid encoding a glucosyl transferase capable of modifying theO4 antigen with glucose branching to produce the glucosylated O4 antigen polysaccharide. Bioconjugates of anglucosylated O4 antigen polysaccharide described herein can be used alone or in combination with one or more additionalO-antigen polysaccharides to induce antibodies against anglucosylated antigen, and to vaccinate a subject against extra-intestinal pathogenic(ExPEC).


Find Patent Forward Citations

Loading…